Patient-reported outcomes in breast cancer FDA drug labels and review documents

• المؤلفون الرئيسيون: Kyungwan Hong (مؤلف), Kayleigh R. Majercak (مؤلف), Ester Villalonga-Olives (مؤلف), Eleanor M. Perfetto (مؤلف)
• التنسيق: كتاب
• منشور في: SpringerOpen, 2021-04-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Background Patient-reported outcomes (PROs) can provide valuable information about drug benefit-risk tradeoffs from the patient perspective and are particularly important to patients with breast cancer due to its symptoms and adverse events from breast cancer treatments. The United States F...